Evidence map›Paper›PMID 39935249›Full record

ArticleEpidemiology and infection2025

Towards more transparent risk assessment of communicable diseases - Redefining probability and impact.

Maarten Nauta, Lasse Engbo Christiansen, Stine Kjær Lefèvre, Charlotte Louise Munkstrup, Johanna Young, Hanne Rosenquist

Abstract read
In one paragraph

Article in Epidemiology and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maarten NautaEpidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen S, Denmark.ORCID 0000-0001-8738-4251
Lasse Engbo ChristiansenEpidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen S, Denmark.
Stine Kjær LefèvreEpidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen S, Denmark.
Charlotte Louise MunkstrupEpidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen S, Denmark.
Johanna YoungEpidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen S, Denmark.ORCID 0000-0002-1788-1903
Hanne RosenquistEpidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen S, Denmark.

Funding

European Union’s EU4Health programmeHaDEA
6 · The paper itself

Abstract

Epidemic preparedness requires clear procedures and guidelines when a rapid risk assessment of a communicable disease threat is requested. In an evaluation of past risk assessments, we found that modifications to existing guidelines, such as the European Centre for Disease Prevention and Control's (ECDC) rapid risk assessment operational tool, can strengthen this process. Therefore, we present alternative guidelines, in which we propose a unifying risk assessment terminology, describe how the risk question should be phrased by the risk manager, and redefine the probability and impact dimension of risk, including a methodology to express uncertainty. In our approach, probability refers to the probability of the introduction of a disease into a specified population in a specified time period, and impact combines the magnitude of spread and the severity of the health outcomes. Based on the collected evidence, both the probability of introduction and the magnitude of spread are quantitatively expressed by expert judgements, providing unambiguous risk assessment. We advise not to summarize the risk by a single qualification as 'low' or 'high'. These alternative guidelines, which are illustrated by a hypothetical example on mpox, have been implemented at Statens Serum Institut in Denmark and can benefit other public health institutes.

Indexed as

Communicable DiseasesDenmarkGuidelines as TopicHumansProbabilityRisk AssessmentEmerging infectionsInfectious disease controlPublic healthRapid risk assessmentRisk assessmentUncertainty

Identifiers

PMID39935249
PMCPMC11869063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.